Aminopurvalanol A
CAS No. 220792-57-4
Aminopurvalanol A ( —— )
Catalog No. M27529 CAS No. 220792-57-4
Aminopurvalanol A is a competitive, selective and cell-permeable inhibitor of cyclin-dependent kinase (CDK) that potently inhibits Cyclin A/cdk2, Cyclin B/cdk1, Cyclin E/cdk2, and P35/cdk5 with IC50 of 33 nM, 33 nM, 28 nM and 20 nM, respectively.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
2MG | 53 | Get Quote |
|
5MG | 87 | Get Quote |
|
10MG | 147 | Get Quote |
|
25MG | 290 | Get Quote |
|
50MG | 447 | Get Quote |
|
100MG | 651 | Get Quote |
|
500MG | 1368 | Get Quote |
|
1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameAminopurvalanol A
-
NoteResearch use only, not for human use.
-
Brief DescriptionAminopurvalanol A is a competitive, selective and cell-permeable inhibitor of cyclin-dependent kinase (CDK) that potently inhibits Cyclin A/cdk2, Cyclin B/cdk1, Cyclin E/cdk2, and P35/cdk5 with IC50 of 33 nM, 33 nM, 28 nM and 20 nM, respectively.
-
DescriptionAminopurvalanol A is a competitive, selective and cell-permeable inhibitor of cyclin-dependent kinase (CDK) that potently inhibits Cyclin A/cdk2, Cyclin B/cdk1, Cyclin E/cdk2, and P35/cdk5 with IC50 of 33 nM, 33 nM, 28 nM and 20 nM, respectively.
-
Synonyms——
-
PathwayAngiogenesis
-
TargetCDK
-
RecptorGap Junction Protein;FTO
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number220792-57-4
-
Formula Weight403.9
-
Molecular FormulaC19H26ClN7O
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCC(C)[C@H](CO)Nc(nc1Nc2cc(N)cc(Cl)c2)nc2c1ncn2C(C)C
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Eleftheriou CG, et al. Meclofenamic acid improves the signal to noise ratio for visual responses produced by ectopicexpression of human rod opsin. Mol Vis. 2017 Jun 16;23:334-345. eCollection 2017.
molnova catalog
related products
-
RO5454291
RO5258638 is a small molecule inhibitor of CDK5-p25 protein-protein interaction with IC50 of 1.39 uM.
-
Mevociclib
Mevociclib is a highly selective covalent inhibitor of CDK7. SY-1365 possesses therapeutic potential in both hematological and solid tumors.
-
Dinaciclib
A potent and selective CDK inhibitor with IC50 of 1, 1, 3 and 4 nM against CDK2, CDK5, CDK1 and CDK9, respectively.